Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.600
-0.110 (-6.43%)
Mar 31, 2025, 9:55 AM EDT - Market open
Sana Biotechnology Stock Forecast
SANA's stock price has decreased by -82.9% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Sana Biotechnology stock have an average target of 9.50, with a low estimate of 5.00 and a high estimate of 15. The average target predicts an increase of 493.75% from the current stock price of 1.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
Buy | 1 | 0 | 0 | 0 | 0 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 3 | 3 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +212.50% | Mar 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +587.50% | Mar 18, 2025 |
Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +337.50% | Mar 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +587.50% | Jan 8, 2025 |
TD Cowen | TD Cowen | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
Financial Forecast
Revenue This Year
n/a
from 146.06M
Revenue Next Year
n/a
EPS This Year
-0.89
from -1.16
EPS Next Year
-0.94
from -0.89
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 123.4M | ||
Avg | n/a | n/a | 44.7M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.66 | -0.60 |
Avg | -0.89 | -0.94 |
Low | -1.13 | -1.70 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.